Anti-csfr1 Antibody And Anti Pd-1 Antibody Combination Therapy For Cancer

Abstract

Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.


Claims
CPC Classifications

Download Citation


Sign in to the Lens

Feedback